(Q43199587)

English

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis

scientific article published on 8 January 2010

Statements

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis (English)
Myrthe P P van Herk-Sukel
Lonneke V van de Poll-Franse
Adri C Voogd
Grard A P Nieuwenhuijzen
Jan Willem W Coebergh
Ron M C Herings
8 January 2010
843-851

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit